This study evaluated the efficacy of elranatamab (Elrexfio, Pfizer), which targets B-cell maturation antigen ... elranatamab for patients with multiple myeloma who are relapsed/refractory after ...

Multiple myeloma is a rare type of cancer. It starts with the uncontrolled production of plasma cells. These are a type of white blood cell in the bone marrow. Healthy plasma cells make antibodies ...